Adnan M. M. Mjalli

Founder at Bien-Etre Labs LLC

Adnan M. M. Mjalli

Adnan M. M. Mjalli

Founder at Bien-Etre Labs LLC

Overview
Career Highlights

MiG 2.0
PharmaCore, Inc.
High Point Clinical Trials Cente

RelSci Relationships

777

Number of Boards

13

Birthday

1964

Age

56

Relationships
RelSci Relationships are individuals Adnan M. M. Mjalli likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Financial Officer, Treasurer, Secretary at MAFS Acquisition Corp.

Relationship likelihood: Strong

President & Chief Executive Officer at The American Task Force for Lebanon

Relationship likelihood: Strong

Cardiovascular Surgery at The Mount Sinai Hospital

Relationship likelihood: Strong

President & Chief Executive Officer at vTv Therapeutics, Inc.

Relationship likelihood: Strong

Partner at McKenna Long & Aldridge LLP

Relationship likelihood: Strong

President at High Point Clinical Trials Center

Relationship likelihood: Strong

Former Regional President-Western Kentucky at Truist Financial Corp.

Relationship likelihood: Strong

Chairman & Chief Executive Officer at MacAndrews & Forbes Holdings, Inc.

Relationship likelihood: Strong

Vice Chairman Emeritus at MacAndrews & Forbes Holdings, Inc.

Relationship likelihood: Strong

President at High Point University

Relationship likelihood: Strong

In The News
Triad Business Journal (Greensboro, North Carolina)
November 2, 2020
Some aspects of Oasis Village in High Point may be eligible for economic incentives
Triad Business Journal (Greensboro, North Carolina)
October 30, 2020
2020 Power Players: Checking in on this year's 10 to Watch
Triad Business Journal (Greensboro, North Carolina)
October 29, 2020
Proposed $500 million Oasis Village could move from High Point out of state
Paths to Adnan M. M. Mjalli
Potential Connections via
Relationship Science
You
Adnan M. M. Mjalli
Founder at Bien-Etre Labs LLC
Education
Ph.D Medicinal & Pharmaceutical Chemistry
Class of 1989

The University of Exeter is a public research university located in South West England, United Kingdom. The university was founded and received its Royal Charter in 1955, although its predecessor institutions, the Royal Albert Memorial College and the University College of the South West of England, were established in 1900 and 1922 respectively. In post-nominals, the University of Exeter is abbreviated as Exon. (from the Latin Exoniensis), and is the suffix given to honorary and academic degrees from the university. The university has three campuses: Streatham; St Luke's (both of which are in Exeter); and Tremough in Cornwall. The university is centred in the city of Exeter, Devon, where it is the principal higher education institution. Streatham is the largest campus containing many of the university's administrative buildings, and is regarded as one of the most beautiful in the country.The Tremough campus is maintained in conjunction with Falmouth University under the Combined Universities in Cornwall (CUC) initiative. The University of Exeter was named The Sunday Times University of the Year in 2013 and was the Times Higher Education University of the Year in 2007. Exeter has maintained a top ten position in the National Student Survey since the survey was launched in 2005. In 2011, it was considered as being one of the top 12 elite universities in the United Kingdom, and has been consistently ranked as one of the top 10 UK universities in recent years.According to the Sunday Times University Guide 2015, Exeter ranks at #7, making it the best university in the South West of England. Exeter University is a member of the Russell Group of leading research-intensive UK universities.The university is also a member of Universities UK, the European University Association, and the Association of Commonwealth Universities and is an accredited institution of the Association of MBAs (AMBA).

MSc Medicinal & Pharmaceutical Chemistr

Established with a clear vision to excel in teaching, research, innovation and engagement, Salford Business School enjoys an excellent national and international reputation for its courses, teaching quality and the progression of students into responsible positions across a variety of industries. Their emphasis of combining a highly contemporary curriculum with a range of professional development opportunities provides a mix of academic and hands on development.

Memberships
Member
Current

American Chemical Society engages as a scientific society which supports scientific inquiry in the field of Chemistry. The company was founded in 1876 and is headquartered in Washington, DC.

Career History
Chief Development Advisor
2020 - Current

ADAM Project is a private company headquartered in the United States. The firm develops software for medical diagnostics.

Founder
2014 - Current
Chairman & Chief Executive Officer
Current

High Point Clinical Trials Center is a private company headquartered in High Point, NC. The firm provides clinical research services for pharmaceutical industries. It was founded by Adnan M. M. Mjalli, who is currently the CEO of the company.The company says this about itself: High Point Clinical Trials Center is a leading clinical research unit focused on the conduct of early stage clinical pharmacology and POC Studies for bio technology and pharmaceutical companies worldwide. The dedicated trials facility specializes in the execution of Phase I-III clinical trials. In addition to early development studies, HPCTC conducts studies across a range of therapeutic indications including metabolic, respiratory and CNS in a pleasant and comfortable environment managed by caring and experienced staff. Participant safety, protocol adherence, regulatory compliance and effective communication are the company’s top priorities.

Boards & Committees
Chairman & Chief Executive Officer
Current

High Point Clinical Trials Center is a private company headquartered in High Point, NC. The firm provides clinical research services for pharmaceutical industries. It was founded by Adnan M. M. Mjalli, who is currently the CEO of the company.The company says this about itself: High Point Clinical Trials Center is a leading clinical research unit focused on the conduct of early stage clinical pharmacology and POC Studies for bio technology and pharmaceutical companies worldwide. The dedicated trials facility specializes in the execution of Phase I-III clinical trials. In addition to early development studies, HPCTC conducts studies across a range of therapeutic indications including metabolic, respiratory and CNS in a pleasant and comfortable environment managed by caring and experienced staff. Participant safety, protocol adherence, regulatory compliance and effective communication are the company’s top priorities.

Director
2004 - 2009

SIGA Technologies, Inc. engages in the development and commercialization of solutions for serious unmet medical needs and biothreats. The company develops therapeutic solutions for lethal pathogens including smallpox, Ebola, dengue, Lassa fever, and other dangerous viruses. It offers an orally administered antiviral drug that targets orthopoxviruses under the TPOXX brand. The company was founded by Steven Oliveira on December 28, 1995 and is headquartered in New York, NY.

Trustee
Current

THE MISSION OF HIGH POINT UNIVERSITY IS TO DELIVER EDUCATIONAL EXPERIENCES THAT ENLIGHTEN, CHALLENGE, AND PREPARE STUDENTS TO LEAD LIVES OF SIGNIFICANCE IN COMPLEX GLOBAL COMMUNITIES. THE VISION OF HIGH POINT UNIVERSITY IS TO BE A NATIONALLY PROMINENT, PRIVATE INSTITUTION RECOGNIZED FOR THE EXCELLENCE OF ITS ACADEMIC PROGRAMS, THE DEPTH OF ITS VALUES-BASED CULTURE, THE BREADTH OF ITS INCLUSIVENESS, AND THE STRENGTH OF ITS COMMITMENT TO HELPING STUDENTS LEAD LIVES OF SIGNIFICANCE.

Director
Current

TO PROMOTE UNDERSTANDING & COOPERATION BETWEEN THE U.S. AND LEBANON IN CULTURAL, HUMANITARIAN AND ECONOMIC MATTERS.

Director
Current
Director
Prior

High Point Economic Development Corp. operates as a city department which is a public-private partnership. It works with office, industrial, and retail clients. The company is headquartered in High Point, NC.

Political Donations
$1,000
2013
$4,000
2010

Former Governor of North Carolina

$1,000
2008

Former Governor of North Carolina

Investments
Details Hidden

VTVX Holdings I LLC discovers, develops and commercializes human therapeutics to fill unmet medical needs. Its products include a pipeline of small molecule clinical and pre-clinical drug candidates for the treatment of a range of human diseases, including central nervous system disorders, cardiovascular disorders, type I/II diabetes, obesity, metabolic diseases, inflammatory diseases, female sexual dysfunction, primary open angle glaucoma and cancer. The company was founded in 1998 by Dr. Adnan M. M. Mjalli and is headquartered in High Point, NC.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Adnan M. M. Mjalli. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Adnan M. M. Mjalli's profile does not indicate a business or promotional relationship of any kind between RelSci and Adnan M. M. Mjalli.